The oil diseaster in Spain;Teil V. Die Spanische olkatastrophe

Umweltmedizin in Forschung und Praxis

Volumn 5, Issue 5, 2000, Pages 285-292

  Seidel, H J ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Contaminated food; Diagnostic criteria; Epidemiology; Risk management; Toxic oil syndrome

Indexed keywords

ANILINE DERIVATIVE; OLEOYLANILIDE; TRYPTOPHAN; UNCLASSIFIED DRUG; VEGETABLE OIL;

ARTICLE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; EOSINOPHILIA; FOOD CONTAMINATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; MYALGIA; PREVALENCE; RISK MANAGEMENT; SPAIN; TOXIC OIL SYNDROME; WORLD HEALTH ORGANIZATION;

EID: 0033773763     PISSN: 14308681     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. The toxic oil syndrome (TOS, 1981): From the disease towards a toxicological understanding of its chemical aetiology and mechanism
2. Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients
3. Toxic oil syndrome: A syndrome with features overlapping those of various forms of scleroderma
4. The neurotoxicological aspects of the toxic oil syndrome in Spain
5. 'Spanish oil' not neurotoxic in rats
6. Toxic oil syndrome - An example of an exogenously-induced autoimmune disease
7. Compositional analysis of oil samples implicated in the Spanish toxic oil syndrome
8. Toxic oil syndrome, chemical and immunological characteristics: A review
9. Mortality among people affected by toxic oil syndrome
10. Oil ingestion and the toxic oil syndrome: Results of a survey of residents in the Orcasur neighbourhood in Madrid, Spain
11. Sindrome toxico por consumo de aceite adulterado
12. A comparsion of the acute pathology induced by 3-phenylamino-1,2-propanediol (PAP) and its mono-oleoyl ester in rodents with the toxic oil syndrome in man
13. Cytokine in RNA expressive in lung tissue from toxic oil syndrome patients: A TH 2 immunological mechanism
14. The association of oil ingestion with toxic oil syndrome in two convents
15. The toxic oil syndrome: A continuing challenge
16. Persistence of respiratory abnormalities four years after the onset of toxic oil syndrome
17. Epidemiologia del sindrome toxico
18. Dynamic pulmonary arterial hypertension: A new form of pulmonary hypertension in patients with impaired pulmonary diffusing capacity due to the toxic oil syndrome
19. Toxilogists versus toxicological disasters: Toxic oil syndrome, clinical aspects
20. Repercusiones del sindrome toxico sobre la gestacion
21. Analysis of polychlorinated dioxins and furans in samples of the toxic oil syndrome
22. Detection and isolation of pentachlorophenol in oil samples associated with the spanish oil syndrome
23. The eosinophilia myalgia syndrome and the toxic oil syndrome. Pursuing parallels
24. Possible etiologic agents for toxic oil syndrome: Fatty acid esters of 3-(n-phenylamino)-1,2-propanediol
25. The toxic oil syndrome
26. Histologic abnormalities of large and small coronary arteries, neural structures, and the conduction system of the heart found in postmortem studies of individuals dying from the toxic oil syndrome
27. Fatty acid anilides: In vivo formation and relevance to toxic oil syndrome
28. 12 Year follow up study of epidemic Spanish toxic oil syndrome
29. Toxicity of oleic acid anilide in rats
30. Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain
31. Toxic oil syndrome: A current clinical and epidemiologic summary, including comparisons with the eosinophilia myalgia syndrome
32. Clinical epidemiology of toxic oil syndrome. Manifestations of a new illness
33. Immunological aspects of the toxic oil syndrome
34. Extracardiac vascular and neural lesions in the toxic oil syndrome
35. Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino) alanine: A chemical link between toxic oil syndrome and eosinophilia myalgia syndrome
36. Sindrome toxico x epidemiologia. Distribucion espacial
37. The toxic oil syndrome: A new case of the carpalttunnel syndrome
38. Spanish toxic oil syndrome. Ten years after the disaster
39. 3-(Phenylamino) alanine - A link between eosinophilia myalgia syndrome and toxic oil syndrome?
40. Toxic oil syndrome and eosinophilia myalgia syndrome: May 8-10, 1991, WHO Meeting Report
41. Epidemiology of the toxic oil syndrome
42. Toxic oil syndrome case reports associated with the ITH oil refinery in Sevilla
43. Late cases of toxic oil syndrome: Evidence that the aetiological agent persisted in oil stored for up to one year
44. Manufacturing processes at two French rapseed oil companies: Possible relationships to the toxic oil syndrome in Spain
45. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain
46. Toxic oil syndrome: Traceback of the toxic oil and evidence for a point source epidemic
47. Neurotoxicity of fatty acid anilides in rabbits
48. Review of L-tryptophan and eosinophilia myalgia syndrome
49. Yusho-Krankheit (Olkrankheit)
50. Eosinophilia myalgia syndrome associated with exposure to tryptophan from a single manufacturer
51. Eosinophilia myalgia syndrome; results of national surveillance
52. Toxic allergic syndrome caused by ingestion of rapseed oil denatured with aniline
53. Spanish toxic oil and congenital malformations
54. Toxic epidemic syndrome, Spain 1981
55. Toxic oil syndrome. Massfood poisoning in Spain
56. The toxic oil syndrome: A perspective on immuntoxicological mechanisms